Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Medicines
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Cannabis
Wednesday, 23 October
13:20
Treatment — challenges, determinants and responses
13:20
to
14:50
Networking zone 3 (N3)
Dominique Lopez
18:30
Innovative approaches for assessing or impacting demand for substances
18:30
to
19:30
Central square 1 (C1)
Anne Line Bretteville-Jensen
Thursday, 24 October
13:20
Focus on prescription drugs I
13:20
to
14:50
Insights zone 3 (I3)
Volker Auwärter
16:50
Methods and measurement of economic cost of substance use
16:50
to
18:20
Central square 3 (C3)
Rosalie Pacula
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
13:30
Short communication
Treating drug abuse and health issues in the criminal justice system. An empirical research on the linkage of health and criminal justice interventions, France
13:30
to
13:40
Networking zone 3 (N3)
Ivana Obradovic
Short communication
Perceptions on social determinants of opioid dependence recovery
13:30
to
13:40
Networking zone 3 (N3)
Leonor Brito
13:40
Short communication
Reverse transition from injecting to smoking heroin and/or crack cocaine on lower methadone dose: sub-therapeutic dosing or safer drug use?
13:40
to
13:50
Networking zone 3 (N3)
Felicia Heidebrecht
13:50
Short communication
Benzodiazepine management in primary care: barriers and facilitators
13:50
to
14:00
Networking zone 3 (N3)
Kristien Coteur
14:00
Short communication
Referral of European and third country non-national clients in Belgian drug treatment
14:00
to
14:15
Networking zone 3 (N3)
Eva Blomme
14:10
Short communication
HIV and drug abuse: relationship and treatment challenges
14:10
to
14:20
Networking zone 3 (N3)
Sara Dehanov
14:20
Short communication
Motivation for treatment predict adherence to treatment in a randomised clinical trial
14:20
to
14:30
Networking zone 3 (N3)
Zhanna Gaulen
14:30
Short communication
Psychiatric assessment of prisoners in opioid-maintenance treatment: emphasis on ADHD
14:30
to
14:40
Networking zone 3 (N3)
Marisa Silbernagl
14:40
Short communication
Perceptions on social determinants of opioid dependence recovery
14:40
to
14:50
Networking zone 3 (N3)
18:30
Oral presentation
USODROGAS.PT: Portugal's drug use: a web based survey
18:30
to
18:45
Central square 1 (C1)
André Tadeu
18:45
Oral presentation
Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research project
18:45
to
19:00
Central square 1 (C1)
Henning Pettersen
19:00
Oral presentation
Validation of the Routine Opioid Outcome Monitoring (ROOM) screening tool in patients prescribed opioids for chronic pain
19:00
to
19:15
Central square 1 (C1)
Suzanne Nielsen
19:15
Oral presentation
Adoption of publication procedures to improve research integrity by alcohol and other drug journals
19:15
to
19:30
Central square 1 (C1)
Dennis Gorman
Thursday, 24 October
13:30
Oral presentation
The off-prescription use of modafinil: an online survey of perceived risks and benefits
13:30
to
13:45
Insights zone 3 (I3)
Rachel Teodorini
13:45
Oral presentation
Prospective cohort to assess the impact of removing non-prescription codeine in Australia
13:45
to
14:00
Insights zone 3 (I3)
Jacqui McCoy
14:00
Oral presentation
Characteristics and problematic opioid use in people prescribed opioids for CNCP over four years: a prospective cohort study
14:00
to
14:15
Insights zone 3 (I3)
Gabrielle Campbell
14:15
Oral presentation
A qualitative study of gabapentin use and misuse: perspectives of substance abuse treatment professionals
14:15
to
14:30
Insights zone 3 (I3)
Mance Buttram
16:50
Oral presentation
Modeling economical costs of alcohol consumption in Germany: the GECO-ALC1 project
16:50
to
17:05
Central square 3 (C3)
Jakob Manthey
17:05
Oral presentation
Estimating substance use costs and harms in Canada
17:05
to
17:20
Central square 3 (C3)
Matthew Young
17:20
Oral presentation
Morbi-mortality consequences of misuse of psychoactive prescription drugs in Portugal: a retrospective observational study - the MisuMedPT project
17:20
to
17:35
Central square 3 (C3)
Ana Araújo